Integrated Wealth Concepts’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.14M Buy
24,565
+2,830
+13% +$353K 0.03% 588
2025
Q4
$2.65M Sell
21,735
-4,217
-16% -$484K 0.03% 455
2025
Q3
$2.6M Sell
25,952
-5,464
-17% -$492K 0.02% 579
2025
Q2
$2.61M Sell
31,416
-3,489
-10% -$278K 0.03% 536
2025
Q1
$2.83M Buy
34,905
+7,780
+29% +$695K 0.03% 487
2024
Q4
$2.44M Buy
27,125
+5,701
+27% +$552K 0.03% 498
2024
Q3
$2.12M Sell
21,424
-11,002
-34% -$1.08M 0.03% 532
2024
Q2
$3.01M Buy
32,426
+9,230
+40% +$828K 0.04% 385
2024
Q1
$2.2M Buy
23,196
+1,698
+8% +$158K 0.03% 491
2023
Q4
$1.92M Sell
21,498
-2,158
-9% -$160K 0.03% 500
2023
Q3
$1.73M Buy
23,656
+2,021
+9% +$161K 0.03% 499
2023
Q2
$1.8M Buy
21,635
+155
+0.7% +$13K 0.03% 502
2023
Q1
$1.64M Buy
21,480
+791
+4% +$65.6K 0.03% 473
2022
Q4
$1.72M Buy
20,689
+4,122
+25% +$334K 0.05% 349
2022
Q3
$1.31M Sell
16,567
-1,370
-8% -$115K 0.04% 364
2022
Q2
$1.33M Buy
17,937
+130
+0.7% +$9.76K 0.04% 371
2022
Q1
$1.6M Buy
17,807
+1,766
+11% +$163K 0.05% 299
2021
Q4
$1.8M Buy
16,041
+2,171
+16% +$262K 0.05% 284
2021
Q3
$1.74M Buy
13,870
+2,434
+21% +$313K 0.06% 267
2021
Q2
$1.55M Buy
11,436
+3,231
+39% +$425K 0.05% 262
2021
Q1
$1.11M Sell
8,205
-602
-7% -$90.1K 0.05% 274
2020
Q4
$1.24M Sell
8,807
-48
-0.5% -$6.15K 0.06% 214
2020
Q3
$987K Buy
8,855
+545
+7% +$61.1K 0.06% 220
2020
Q2
$930K Buy
8,310
+1,392
+20% +$137K 0.07% 190
2020
Q1
$536K Buy
+6,918
New +$613K 0.05% 218

Other funds holding XBI

Integrated Wealth Concepts's XBI Position: Q1 2026 in Review

Integrated Wealth Concepts increased its State Street SPDR S&P Biotech ETF (XBI) stake by 13% in Q1 2026, buying an estimated $353K and bringing the position to 24,565 shares worth $3.14M. The position accounts for 0.03% of the portfolio, ranked #588.

Integrated Wealth Concepts first reported a position in XBI in Q1 2020 and has held it in 25 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Integrated Wealth Concepts held 24,565 shares of State Street SPDR S&P Biotech ETF worth $3.14M as of Q1 2026.
  • Integrated Wealth Concepts bought 2,830 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $353K.
  • State Street SPDR S&P Biotech ETF made up 0.03% of Integrated Wealth Concepts's portfolio in Q1 2026, its #588 holding.
  • Integrated Wealth Concepts first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 25 quarters since.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.